Cargando…
Long-term outcome and chest pain in patients with true versus non-true bifurcation lesions treated with second-generation drug-eluting stents in the TWENTE trial
The objective of this study is to assess 3-year clinical outcome of patients with true bifurcation lesions (TBLs) versus non-true bifurcation lesions (non-TBLs) following treatment with second-generation drug-eluting stents (DES). TBLs are characterized by the obstruction of both main vessel and sid...
Autores principales: | van Houwelingen, K. Gert, van der Heijden, Liefke C., Lam, Ming Kai, Kok, Marlies M., Löwik, Marije M., Louwerenburg, J. W., Linssen, Gerard C. M., IJzerman, Maarten J., Doggen, Carine J. M., von Birgelen, Clemens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085988/ https://www.ncbi.nlm.nih.gov/pubmed/26747438 http://dx.doi.org/10.1007/s00380-015-0786-6 |
Ejemplares similares
-
Bifurcation treatment with novel, highly flexible drug-eluting coronary stents in all-comers: 2-year outcome in patients of the DUTCH PEERS trial
por: van der Heijden, Liefke C., et al.
Publicado: (2015) -
Long‐Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer‐Generation Drug‐Eluting Stents
por: van der Heijden, Liefke C., et al.
Publicado: (2018) -
High Bleeding Risk Patients Treated with Very Thin-Strut Biodegradable Polymer or Thin-Strut Durable Polymer Drug-Eluting Stents in the BIO-RESORT Trial
por: Zocca, Paolo, et al.
Publicado: (2018) -
Final 5‐Year Report of the Randomized BIO‐RESORT Trial Comparing 3 Contemporary Drug‐Eluting Stents in All‐Comers
por: Ploumen, Eline H., et al.
Publicado: (2022) -
Three‐year clinical outcome in all‐comers with “silent” diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug‐eluting stents: From the BIO‐RESORT Silent Diabetes study
por: Ploumen, Eline H., et al.
Publicado: (2019)